civilization by the temporary relief of tablets, may well be condemned in its turn by later generations, as we now tend to condemn the 'tonic'.
Prescribing habits need constant re-examination and re-appraisal. It is a salutary experience to learn by examining the bathroom cupboard how many of your prescriptions have been dispensed only to remain shut up in their moist entirety, while you congratulated the patient on his recoveryand yourself on your pharmacological acumen. It is valuable, too, to review one's habits in the light of modern knowledge of the effects of drugs in combination, that, for example, salicylates in combination with oral antidiabetic drugs cause potentiation of their hypoglycaemic effect, or with warfarin may potentiate its anticoagulant effect.
In fact, in prescribing, as in so many other spheres, blind habit is a snare, but carefully formed habits are valuable and time saving. We all need time to select, from the mass of material thrust on us from all sides, those drugs which really will help our patients in the quickest and safest way, and to do this we must use every means available of acquiring impartial information. But above all we must try to retain, as it were, a due sense of questioning independence of mind over our habits of prescribing, so that as family doctors our special knowledge of our patients may help us to select the treatment for them that is most appropriate for their particular circumstances. The first essential for a prescription is that it be so written that the intention of the prescriber can be clearly understood by the dispenser, both as to content and method of use. Providing this is done it is not, in my view, important whether the prescription is written in Latin, abbreviated Latin, English or indeed a mixture of all three.
REFERENCE
Until recent times, the vast majority of prescriptions were compounded (secundum artem) in the pharmacy, the names of the drugs used coming mostly from the botanical names of the plants which produced them. The use of abbreviated Latin was, therefore, most convenient. Each medicament prescribed would normally contain a number of ingredients. If, therefore, one ingredient was indecipherable the others would lend clues to its identity. Today, a large percentage of the items prescribed have been formulated and compounded by the pharmaceutical industry. A brand name is attached and if it is indecipherable the dispenser will have no clue as to its identity, unless, perhaps, another medicament is prescribed simultaneously. It has thus become increasingly important for the prescription to be written in such a way that the prescriber's intention is never in doubt.
There are slightly different legal requirements to be complied with in dispensing private and NHS prescriptions. It is my intention to confine myself in the main to NHS prescriptions.
There are three classes of medicines that may not be supplied to the public except on prescription. These are controlled by the following Acts and Regulations:
(1) The Therapeutic Substances Act (TSA) and Regulations: Drugs covered by these include most antibiotics and corticosteroids, isoniazid and its derivatives. All prescriptions must be signed and dated by the prescriber.
(2) Schedule 4. Poisons: We are concerned with Part a and Part b of the fourth schedule; 4b, for example, includes oral contraceptives and 4a the barbiturates, &c. In both cases the prescription must be in writing and must be signed anci dated by the prescriber. If coming under 4a it must also include: (i) Address of prescriber (except in the case of an NHS prescription). (ii) Name and address of patient. (iii) Total amount to be supplied (except in the case of BNF preparations). (iv) The dose (except in the case of external preparations). Unless the prescription contains all these particulars the pharmacist is not permitted to supply the medicine.
(3) The Dangerous Drugs Act (DDA): The requirements for prescriptions calling for the supply of drugs controlled under this Act differ slightly from those of Schedule 4 and TSA, in that the pharmacist must be acquainted with the signature of the prescriber or have taken reasonably sufficient steps to assure himself that it is genuine.
Proc. roy. Soc. Med. Volume 61 June 1968 By far the biggest problem that arises is caused by the handwriting of the prescriber. During the past few years the number of new drugs and their potency has been increasing at an almost alarming rate; careless handwriting by the prescriber is, therefore, inexcusable. When in doubt the pharmacist will always refer back to the prescriber. But This list is by no means exhaustive but does, I hope, serve to underline my point.
Confusion is not always the result of bad or careless handwriting. Sometimes it is due to the prescriber not being quite sure of the name of the preparation, unable to spell it or indeed failing to read the letter sent to him by the consultant or hospital and copying it in the hope that the dispenser will recognize what is required.
Another problem is the incomplete prescription where the prescriber has failed to provide one or more of the essential particulars. It is a cardinal point with pharmacists that confidence between the patient and his doctor is vital and anything that is likely to disturb this confidence is to be avoided if at all possible. The pharmacist is therefore reluctant to allow the patient to see that he is in any doubt about the prescription.
In the case of a prescription coming within the scope of the DDA Regulations the pharmacist has no option, if the prescription is incomplete, but to return it. In all other cases he will go to a very great deal of trouble to avoid doing so.
There is not the slightest doubt that in the writing of prescriptions, many GPs have developed what can only be described as bad habits. For example: The brand name is given without any indication to the dispenser as to the form in which it is to be dispensed, i.e., tabs, caps, liquid, &c.
A prescribing habit that seems to be gaining ground these days is for the doctor to discuss the instructions for use with the patient and then to omit any directions at all on the prescription or to content himself by stating: Sig, 'As before', 'As directed' or 'When required'. This I believe to be a dangerous habit which is also discourteous to the dispenser and frequently places the pharmacist in the difficult situation of trying to ensure that the safety of the patient is looked after, while at the same time maintaining the patient's confidence in his doctor. It should be remembered that memory is an unreliable vehicle for such important information as the dose to be taken of a highly potent medicine.
The use of 'NP' or 'nomen proprium' poses many problems, one of which I encountered a few days ago. A patient looked at the label on her bottle of tablets and said: 'Why has he given me phenobarbitone? That's what Mrs Jones next door takes for her fits. Does he think I'm going to start having fits?' Attempts at reassurance brought the further complication when she said: 'Mrs Jones only takes them twice a day but it says here three times a day'.
The habit of prescribing for more than one patient on the same form is a constant source of worry, e.g.:
Baby Jones, age 14 months Penicillin suspension 125 mg Q.q.h. Caps Sod. Amytal, gr 3 -1 or 2 at night In this case enquiry elicited the fact that the capsules were for the mother.
The prescribing of an unusually large quantity of medicine whose keeping properties were limited turned out to be a communal bottle for the family. Directions had been given verbally as to how much each member was to take for a dose. The dose on the prescription was that for the member whose name would appear on the label. Quite apart from the fact that the doctor in this case was breaking the NHS regulations, he was making it impossible for the pharmacist to exercise his responsibility to ensure the safety of the patient.
There seems to be an increasing tendency to 'improve' a branded product by diluting it, mixing it with one or more other products, adding an additional ingredient or ingredients. This is particularly the case with certain ointments when the branded ointment is prescribed 1 in 10. The difficulty arises when the diluent is named by a prescriber who is not familiar with the base used by the manufacturer. May f make a plea that the choice of diluent be left to the pharmacist, unless the prescriber is certain that the .22 efficacy of the preparation will not be impaired by the diluent of his (the prescriber's) choice.
Finally, may I make a plea for a much closer liaison between the general medical practitioner and the general pharmaceutical practitioner. I am convinced that only good for the patient can come out of this co-operation.
Professor J R Trounce (Department ofClinicalPharmacology, Guy's Hospital, London)
Continuing Education in Clinical Pharmacology
In 1967 I published a short survey of prescribing in general practice. Two interesting patterns emerged from this investigation. One was that when the disease being treated was a clear-cut entity with a clear-cut remedy, the practitioner and orthodoxy in the shape of the National Formulary usually agreed as to the correct drug. In the more misty areas of diagnosis, however, as one might expect, there was a considerable difference of opinion as to the correct treatment. The other striking fact was the large proportion of drugs prescribed as proprietary preparations. This investigation led to a consideration of the factors which influence the practitioner in his prescribing and finally how information about new drugs and therapeutics could best be supplied to those in practice.
A questionnaire was sent to 100 Guy's Hospital graduates; 50 were in general practice and had qualified between 1940 and 1950, and 50 had qualified within the last two years. Both groups were asked for their views on various aspects of postgraduate education in therapeutics and in addition the recently qualified group were asked their views on undergraduate education. It is realized that these groups were very small and, further, being the product of a single medical school might not reflect the overall views of practitioners, but the replies do give some idea of the views of doctors in practice. Replies have been received from 37 out of 50 of the recent graduates and from 43 out of 50 of those in general practice.
The questions asked and the replies received are given in Tables 1-4. It would seem from their replies that both groups find that advice from colleagues is most valuable. A direct comparison between the National Formulary and MIMS shows that the National Formulary is less popular particularly with the older doctors, and it does not contain the most recently introduced drugs. Finally, Proplist found little favour with either group -it is, however, only fair to say that the Proplist is a relatively recent introduction and judgment on its popularity should be suspended for the present. The drug company representative is appreciated by a number of those in practice. Wilson and his colleagues (1963) in a larger survey also found that older practitioners thought representatives useful. This may be due to the need for somebody to give dogmatic information about drugs.
Finally, both groups were asked for suggestions as to how information about drugs and therapeutics could be best presented. The young Table 1 Question: Which of the following do you find most useful as a guide to the use of drugs? (36) (2) National Formulary (17) (2) National Formulary (7) (8) Useless (14) Objectionable (7) Objectionable (5) No comment (10) 
